RDM1P1

Across TCGA pan-cancer cohorts, RDM1P1 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RDM1P1 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RDM1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RDM1P1 expression acts as an unfavorable survival marker, although some lineages such as BRCA show a favorable association.

LUSC, STAD, and BRCA are the cancer types where RDM1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	II,III,IV	0.201	0.712	<.001	54	view →
STAD	OS	Tertile	III,IV	0.333	0.640	.004	51	view →
BRCA	OS	Tertile	II,III,IV	0.968	0.957	.049	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RDM1P1–LUSC (DFS)

Open the LUSC breakdown →